Investigating immune biomarkers during the progression of Mycobacterium tuberculosis infection

Investigating immune biomarkers during the progression of Mycobacterium tuberculosis infection

Tuberculosis - causes, symptoms, diagnosis, treatment, pathologyПодробнее

Tuberculosis - causes, symptoms, diagnosis, treatment, pathology

ESM Webinars: Biomarkers for incipient TB and disease progression and cureПодробнее

ESM Webinars: Biomarkers for incipient TB and disease progression and cure

Immune checkpoint inhibitors: recent progress and potential biomarkers - 1i IntroductionПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 1i Introduction

TuberculosisПодробнее

Tuberculosis

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2ii Immune CellsПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2ii Immune Cells

Immune checkpoint inhibitors: recent progress and potential biomarkers - 1ii IntroductionПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 1ii Introduction

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2iii Immune CellsПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2iii Immune Cells

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2iv Immune CellsПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2iv Immune Cells

Immune checkpoint inhibitors: recent progress and potential biomarkers - AbstractПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - Abstract

Immune checkpoint inhibitors: recent progress and potential biomarkers - 4ii NeoantigensПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 4ii Neoantigens

Biomarkers of TB in blood & implications for TB HIV- Stefan Kaufmann (Max Planck)Подробнее

Biomarkers of TB in blood & implications for TB HIV- Stefan Kaufmann (Max Planck)

Immune checkpoint inhibitors: recent progress and potential biomarkers - 6i Epigenetic SignaturesПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 6i Epigenetic Signatures

Immune checkpoint inhibitors: recent progress and potential biomarkers - 7iii Concluding remarksПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 7iii Concluding remarks

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2i Immune CellsПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2i Immune Cells

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2v Immune CellsПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 2v Immune Cells

Mycobacterium tuberculosis - TBПодробнее

Mycobacterium tuberculosis - TB

Immune checkpoint inhibitors: recent progress and potential biomarkers - 7ii Concluding remarksПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 7ii Concluding remarks

Immune checkpoint inhibitors: recent progress and potential biomarkers - 1iii IntroductionПодробнее

Immune checkpoint inhibitors: recent progress and potential biomarkers - 1iii Introduction

From biomarkers to vaccines: how immunology can help end TBПодробнее

From biomarkers to vaccines: how immunology can help end TB

События